Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 429

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1B
Chunk 429
---
  
    $130.52  
     10,816  
    $146.22 
  
    Exercisable, end of year 
     5,795  
    $132.82  
     7,236  
    $159.13 
  
    Weighted average estimated fair value of options granted 
        
    $N/A  
        
    $N/A 

     F-20 

Effective as of the close of business on June 6, 2025 with an effective trading date of June 9, 2025, the Company effected
a 1-for-8 reverse stock split of its common stock. All option share figures, including those for prior periods, have been adjusted retrospectively
to reflect the reverse split. Option balances may not tie exactly to prior period filings due to rounding of fractional shares.

There were no stock option grants during the fiscal years ended March
31, 2025 or March 31, 2024. There were 16,448 RSUs granted during the fiscal year ended March 31, 2025. The weighted average grant date
fair value of RSUs granted during the fiscal year ended March 31, 2025 was $50,000. There were no stock option exercises during the fiscal
years ended March 31, 2025 and 2024.

The table below summarizes nonvested stock options as of March 31,
2025 and changes during the year ended March 31, 2025.

    Schedule of  nonvested shares 

    Shares  
    Weighted Average Grant Date Fair Value 
  
    Nonvested stock options at April 1, 2024 
     3,580  
    $120.13 
  
    Vested 
     (1,628) 
    $138.95 
  
    Forfeited 
     (1,201) 
    $99.19 
  
    Nonvested stock options at March 31, 2025 
     751  

The detail of the options outstanding and exercisable as of March 31,
2025 is as follows:

    Schedule of detail of options outstanding and exercisable by exercise
    price 

    Options Outstanding  
    Options Exercisable 
  
    Exercise Prices 
    Number  Outstanding  
    Weighted  Average  Remaining  Life (Years)  
    Weighted  Average  Exercise  Price